• SENSEX 81,911.01
    31.61 (+0.04%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
  • NSE
    1,994.50 1,994.50(%)
  • Reliance Industries
    1,342.10 1,611.20(%)
  • ICICI Bank
    1,592.20 1,616.70(%)
  • Kalyan Jewellers
    716.00 716.00(%)
  • Cupid
    389.00 389.00(%)
  • HDFC Bank
    813.90 1,017.90(%)
  • Sai Life
    1,881.05 786.15(%)
  • SBI
    1,089.00 1,234.80(%)
  • Kotak Mah. Bank
    494.00 494.00(%)
  • Page Industries
    31,752.10 29,800.00(%)
  • M & M
    3,369.00 2,743.15(%)
  • Gabriel India
    1,690.25 1,690.25(%)
  • Bharti Airtel
    2,071.35 1,726.05(%)
  • Cummins India
    4,311.70 6,142.80(%)
  • N S D L
    815.00 1,180.00(%)
  • Hind.Aeronautics
    4,738.80 3,479.20(%)
  • Avanti Feeds
    798.20 1,592.30(%)
  • Indegene
    672.00 672.00(%)
  • Lenskart Solut.
    738.30 767.40(%)
  • Hindustan Copper
    467.35 759.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kilitch Drugs (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3630.0
  • ISIN : INE729D01010
200.61 3 (1.52%)
  • As on 12 Nov 2026 (EOD)

  • Today’s Low

    198.01

  • Today’s High

    204.79

  • Open

    199.59

  • Perv Close

    197.61

  • 52W Low

    117.25

  • 52W High

    267.90

Key Indicators

  • P/E(TTM)

    25.04

  • Mar.Cap (₹Cr.)

    701.36

  • Div & Yield %

    0.00

  • Book Value(₹)

    98.92

  • Debt-Equity Ratio

    1.52

  • AGM Date

    12-Nov-2026

  • EPS

    8.02

  • P/E Ratio

    25.04

Financials Ratios

  • Debt-Equity Ratio

    0.16

  • Mar.Cap (₹Cr.)

    701.36

  • RONW (%)

    8.28

  • ROCE (%)

    13.30

Score Board

  • Equity (₹ in Cr.)

    34.96

  • BV (₹)

    98.90

  • Sales( ₹ in Cr.)

    188.57

  • NP (in Cr.)

    27.81

  • NP Var(%)

    21.0

  • Div%

    0.0

  • CPS (₹)

    8.60

  • EPS (₹)

    8.00

  • Traded Value (₹ in Lakhs)

    702.20

  • 52 Week High

    267.90

  • 52 Week Low

    117.25

  • Price BSE

    201.0

  • Price NSE

    201.00

  • Market Capital( in Cr.)

    702.20

  • P/C Ratio

    23.30

  • P/E Ratio

    25.30

  • Price Vs.BV

    8.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 188.57 181.59 131.60 117.78 105.16 70.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 188.57 181.59 131.60 117.78 105.16 70.02
Other Income 13.85 13.72 6.19 4.60 4.56 4.19
Stock Adjustments -1.07 1.17 0.12 -0.23 0.05 -1.09
Total Income 201.35 196.48 137.91 122.15 109.77 73.12
EXPENDITURE :            
Raw Materials 87.80 93.19 66.33 58.27 60.29 37.97
Power and Fuel Cost 2.61 2.61 2.36 2.15 2.00 1.57
Employee Cost 12.34 10.03 7.91 7.47 6.15 5.22
Other Manufacturing Expenses 6.95 5.52 4.69 5.37 5.91 5.48
Selling and Administration Expenses 39.37 38.03 26.70 23.08 16.48 11.11
Miscellaneous Expenses 5.27 2.25 3.29 3.88 3.25 2.25
Employee Benefit Expenses 12.34 10.03 7.91 7.47 6.15 5.22
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 154.33 151.64 111.29 100.22 94.08 63.59
Operating Profit 47.02 44.83 26.62 21.94 15.69 9.53
Interest 3.18 2.40 2.02 1.15 0.80 0.88
Gross Profit 43.84 42.43 24.60 20.79 14.89 8.65
Depreciation 2.29 1.74 1.24 1.34 0.96 1.14
Profit Before Tax 41.55 40.69 23.36 19.45 13.93 7.51
Current Tax 10.86 9.85 6.37 4.20 3.63 1.67
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.70 -0.32 -0.59 -0.47 -0.23 -0.31
Reported Net Profit 32.40 31.16 17.57 15.72 10.53 6.16
Extraordinary Items 4.59 8.10 1.01 0.77 1.00 0.94
Adjusted Net Profit 27.81 23.06 16.56 14.95 9.53 5.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 162.69 131.53 113.96 98.24 87.71 81.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 195.09 162.69 131.53 113.96 98.24 87.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.27 19.37 10.93 10.09 6.76 3.97
Earnings Per Share(Adj)-Unit Curr 9.27 9.48 5.35 4.94 3.31 1.94
Book Value 95.25 157.28 138.61 122.53 112.65 105.16
Book Value(Adj)-Unit Curr 95.25 76.96 67.82 59.95 55.12 51.46

Shareholding Pattern

  • Promoter Group

    63.77%

  • Public Share Holding

    36.23%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,258,684 37.92 13,258,684 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,037,662 25.85 9,037,662 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 22,296,346 63.77 22,296,346 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 200 0.00 200 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 36,841 0.11 36,841 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 487 0.00 487 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 174,234 0.50 174,234 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 211,762 0.61 211,762 6
2] Non Institution
Bodies Corporate 248,686 0.71 248,086 71
Clearing Members 53,481 0.15 53,481 16
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 474,808 1.36 474,808 223
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 498,328 1.43 498,328 361
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,196,014 12.00 4,196,014 38
Individuals holding nominal share capital up to Rs. 1 lakh 5,951,716 17.02 5,780,927 11,591
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 800,196 2.29 800,196 1
Sub Total 12,453,456 35.62 12,281,867 12,309
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,961,564 100.00 34,789,975 12,319

Company Background

Kilitch Drugs (India) LtdPharmaceuticals - Indian - Formulations

  • Kilitch Drugs (India) Ltd
  • BSE Code : 3630.0
  • ISIN : INE729D01010

  • Incorporation Year

    1992

  • Registered Office

    C-301/2 MIDC TTC Indl Area
    Pawane Village, Thane,
    Maharashtra-400705

  • Telephone

    91-022-27670322/27680913/65144185

  • FAX

    91-022-27680912

  • Chairman

    Mukund P Mehta

  • Managing Director

    Mukund P Mehta

  • Company Secretary

    Pushpa Nyoupane

  • Auditor

    C Sharat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Kilitch Drugs (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kilitch Drugs 200.85 202.42 188.57 25.04 12.35
Abbott India 26,603.60 7,217.19 6,929.05 34.20 43.78
Astrazeneca Phar 6,431.20 2,304.07 2,275.58 90.47 27.86
Glaxosmi. Pharma 2,655.30 3,932.76 3,790.20 39.45 58.17
Evonile Pharma 1,583.60 393.10 354.33 -1,389.12 15.94
Cipla 1,410.00 20,102.60 18,979.95 42.97 13.88
Bliss GVS Pharma 641.15 773.53 729.81 41.80 12.51
Amrutanjan Healt 507.50 520.13 502.55 25.61 24.16
Fermenta Biotec. 472.10 474.15 450.25 22.31 18.77
Guj. Themis Bio. 388.05 168.25 165.82 103.76 18.05
Ambalal Sarabhai 36.76 19.52 3.94 62.31 6.77